(19)
(11) EP 1 519 723 A1

(12)

(43) Date of publication:
06.04.2005 Bulletin 2005/14

(21) Application number: 03727245.7

(22) Date of filing: 27.05.2003
(51) International Patent Classification (IPC)7A61K 31/426, A61K 31/427, A61K 31/433, A61P 3/04, A61P 3/10, C07D 277/42, C07D 417/04, C07D 277/60, C07D 417/12, C07D 285/12, C07D 285/16
(86) International application number:
PCT/DK2003/000350
(87) International publication number:
WO 2004/002480 (08.01.2004 Gazette 2004/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 27.06.2002 DK 200201006
17.12.2002 DK 200201927

(71) Applicant: NOVO NORDISK A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • LAU, Jesper
    DK-3520 Farum (DK)
  • CHRISTENSEN, Inge, Th ger
    DK-2800 Lyngby (DK)
  • MADSEN, Peter
    DK-2880 Bagsv rd (DK)
  • BLOCH, Paw
    DK-2630 Taastrup (DK)
  • BEHRENS, Carsten
    DK-2200 Copenhagen N (DK)
  • KODRA, János, Kodra
    DK-2100 Copenhagen (DK)
  • NIELSEN, Poul, Enrico
    DK-4140 Borup (DK)
  • Jorgensen, Anker.S.
    DK-2100 Kobenhavn (DK)

(74) Representative: Nilsson, Karin Norvin 
Novo Nordisk A/S,Corporate Patents,Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) NOVEL GLUCAGON ANTAGONISTS/INVERSE AGONISTS